HahnBH, EblingFM. Suppression of NZB/NZW murine nephritis by administration of a syngenic monoclonal antibody to DNA: possible role of anti-idiotypic antibodies.J Clin Invest1983; 71: 728–36.
2.
HahnBH, EblingFM. Suppression of murine lupus nephritis. by administration of an anti-idiotypic antibody to anti-DNA.J Immunol1984; 132: 187-90.
TeitlbaumD, RauchJ, StollarBD, SchwatzRS. In vivo effects of antibodies in MRL mice.J Immunol1984; 132: 1282–5.
5.
MorlandC, MichaelJ, AduED. Anti-idiotype and immunosuppressant treatment of murine lupus.Clin Exp Immunol1991; 83: 126–32.
6.
MendlovicS, BrockeS, ShoenfeldY. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype.Proc Natl Acad Sci USA1988; 85: 2260–4.
7.
MendlovicS, FrickeH, ShoenfeldY, MozesE. The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice.Eur J Immunol1989; 19: 729–34.
8.
IsenbergDA, KatzD, Le PageS. Independent analysis of the 16/6 idiotype lupus model. A role for an environmental factor?J Immunol1991; 147: 4172–7.
9.
EblingFM, AndoDG, Panodian-SahakianN, KalunianKC, HahnBH. Idiotypic spreading promotes the production of pathogenic autoantibodies.J Autoimmunity1988; 1: 47–62.
10.
HarataN, SasakiT, OsakiH. Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin.J Clin Invest1990; 86: 769–76.
11.
CampbellMJ, CarrollW, KonS. Idiotypic vaccination against murine B cell lymphoma: humoral and cellular responses elicited by tumour derived IgM and its molecular subunits.J Immunol1987; 139: 2825–33.
